Effect of Nutritional Intervention Based on Prediction Model on Adult Umbilical Cord Blood Transplantation Patients
Launched by ANHUI PROVINCIAL HOSPITAL · Aug 11, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how personalized nutrition plans can help improve the health and survival of adults who are receiving umbilical cord blood transplants (UCBT). Researchers will use a special model to predict the nutritional needs of each patient and then provide tailored dietary support to see if this makes a difference in their recovery.
To participate in this study, you need to be between 18 and 65 years old, able to communicate, and scheduled to receive a UCBT. It's important that your major organs are functioning well and that you've agreed to participate by signing a consent form. Unfortunately, if you are younger than 18 or older than 65, or if you have certain serious health issues, you won't be eligible. If you join the trial, you'll receive specialized nutritional guidance as part of your care, and your progress will be closely monitored to see how well this approach works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-65 years old, conscious, with language communication skills;
- • UCBT patients to be performed;
- • Major organs without serious dysfunction;
- • The participants agreed to participate in the study and signed the informed consent form.
- Exclusion Criteria:
- • Age \< 18 years old or \> 65 years old or with cognitive impairment can not complete this survey;
- • Failure or recurrence of transplantation;
- • Combined with severe other organ system diseases (such as severe cardiac insufficiency, autoimmune disease, active infection, severe trauma) ;
- • Patients who have difficulty collecting data to complete the nutritional intervention;
- • Patients who asked to withdraw from the study.
About Anhui Provincial Hospital
Anhui Provincial Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to enhance patient outcomes and contribute to the global body of medical knowledge. With a focus on translating research findings into practical applications, Anhui Provincial Hospital is dedicated to fostering collaboration among healthcare professionals and researchers, ensuring that cutting-edge treatments and interventions are accessible to the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hefei, Anhui, China
Patients applied
Trial Officials
Xiaoyu Zhu, Ph.D
Principal Investigator
The First Affiliated Hospital of University of Science and Technology of China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported